Ketamine inhibits the proinflammatory cytokine-induced reduction of cardiac intracellular cAMP accumulation

Anesthesia and Analgesia

Volumn 87, Issue 5, 1998, Pages 1015-1019

  Hill, Gary E ^a   Anderson, Jodi L ^a   Lyden, E R ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; ADENYLATE CYCLASE ACTIVATOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; CYTOKINE; FORSKOLIN; GAMMA INTERFERON; ISOPRENALINE; KETAMINE; TRITIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART MUSCLE CELL; INFLAMMATION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-AGONISTS; ANESTHETICS, DISSOCIATIVE; ANIMALS; CELL LINE; CYCLIC AMP; CYTOKINES; FORSKOLIN; INFLAMMATION; INTRACELLULAR FLUID; ISOPROTERENOL; KETAMINE; MYOCARDIUM; RATS; RECEPTORS, ADRENERGIC, BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031784324     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199811000-00006     Document Type: Article

References (32)

1. Ying S, Robinson DS, Varney V, et al. TNFα mRNA expression in allergic inflammation. Clin Exp Allergy 1991;21:745-50.
2. Matsumori A, Yamada T, Suzuki H, et al. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994;72:561-6.
3. Pinsky MR, Vincent JL, Deviere J, et al. Serum cytokine levels in human septic shock. Chest 1993;103:565-75.
4. Kukielka GL, Smith CW, Manning AM, et al. Induction of interleukin-6 synthesis in the myocardium. Circulation 1995;92: 1866-75.
5. Worrall NK, Pyo RT, Botney MD, et al. Inflammatory cell-derived NO modulates cardiac allograft contractile and electrophysiological function. Am J Physiol 1997;273:H28-37.
6. Gulick T, Chung MK, Pieper SJ, et al. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad Sci USA 1989;86:6753-7.
7. Kips JC, Tavernier J, Pauwels RA. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am Rev Respir Dis 1992; 145:332-6.
8. Emala CW, Kuhl J, Hungerford CL, Hirshman CA. TNF-α inhibits isoproterenol-stimulated adenylyl cyclase activity in cultured airway smooth muscle cells. Am J Physiol 1997;272: L644-50.
9. Hemmingsen C, Nielsen PK, Odorico J. Ketamine in the treatment of bronchospasm during mechanical ventilation. Am J Emerg Med 1994;12:417-20.
10. Reich DL, Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 1989;36:186-97.
11. White PF, Way WL, Trevor AJ. Ketamine: its pharmacology and therapeutic uses. Anesthesiology 1982;56:119-36.
12. Shimaoka M, Iida T, Ohara A, et al. Ketamine inhibits nitric oxide production in mouse-activated macrophage-like cells. Br J Anaesth 1996;77:238-42.
13. Dangel V, Giray J, Ratge D, Wisser H. Regulation of β-adrenoceptor density and mRNA levels in the rat heart cell-line H9c2. Biochem J 1996;317:925-31.
14. Shimizu H, Daly JW, Creveling CR. A radioisotopic method for measuring the formation of adenosine 3′,5′-cyclic monophosphate in incubated slices of brain. J Neurochem 1969;16:1609-19.
15. Toews ML, Hoffman JM, Liewer SA, Arneson-Rotert LJ. Serum-induced sensitization of cyclic AMP accumulation in C62B rat glioma cells. J Pharmacol Exp Ther 1992;262:471-8.
16. Meeker RB, Harden TK. Muscarinic cholinergic receptor-mediated activation of phosphodiesterase. Mol Pharmacol 1982; 22:310-9.
17. Gao M, Ping P, Post S, et al. Increased expression of adenylyl-cyclase type VI proportionately increases β-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 1998;95:1038-43.
18. Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. APMIS 1995;103:161-79.
19. Shalaby MR, Aggarwal BB, Rinkerknecht E, et al. Activation of human polymorphonuclear neutrophil functions by interferon-γ and tumor necrosis factors. J Immunol 1985;135:2069-73.
20. Parrillo JE. Pathogenetic mechanism of septic shock. N Engl J Med 1993;328:1471-7.
21. Chung M, Gulick TS, Rotondo RE, et al. Mechanism of cytokine inhibition of β-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Circ Res 1990;67:753-63.
22. Bensard DD, Banerjee A, McIntyre RC, et al. Endotoxin disrupts β-adrenergic signal transduction in the heart. Arch Surg 1994; 129:198-205.
23. Romano FD, Jones SB. Alterations in β-adrenergic stimulation of myocardial adenylate cyclase in endotoxic rats. Am J Physiol 1986;250:R358-64.
24. Schumann RR, Leong SR, Flaggs GW, et al. Structure and function of lipopolysaccharide binding protein. Science 1990;249: 1429-31.
25. Jimi N, Segawa K, Minami K, et al. Inhibitory effect of the intravenous anesthetic, ketamine, on rat mesangial cell proliferation. Anesth Analg 1997;84:190-5.
26. Biebuyck JF, Dedrick DF, Scherer YD. Brain cyclic AMP and putative transmitter amino acids during anesthesia. In: Fink BR, ed. Molecular mechanisms of anesthesia. New York: Raven 1975:451-70.
27. Takenaka I, Ogata M, Koga K, et al. Ketamine suppresses endotoxin-induced tumor necrosis factor alpha production in mice. Anesthesiology 1994;80:402-8.
28. Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 1996;93:704-11.
29. Yamamoto S, Tsutsui H, Tagawa H, et al. Role of myocyte nitric oxide in β-adrenergic hyporesponsiveness in heart failure. Circulation 1997;95:1111-14.
30. Barnes PJ. Anti-inflammatory therapy for asthma. Annu Rev Med 1993;44:229-42.
31. Idvall J, Ahlgren I, Aronsen KF, Stenberg P. Ketamine infusions: pharmacokinetics and clinical effects. Br J Anaesth 1979;51: 1167-72.
32. Sprung J, Schuetz SM, Stewart RW, Moravec CS. Effects of ketamine on the contractility of failing and nonfailing human heart muscles in vitro. Anesthesiology 1998;88:1202-10.